An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo Nordisk — the Danish drugmaker behind Ozempic and Wegovy — at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid this...
Tag: meds
New prostate cancer medication 'shows promise' in treating aggressive disease, study finds
There may be a “promising new strategy” in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia investigated how the novel drug, CDKI-73, has the potential to tackle drug-resistant prostate cancer. This drug reportedly “defies conventional therapies,” as noted in the study findings,...
Breast cancer drug could help prolong survival for children with brain tumors, study finds
A drug called ribociclib, currently used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer, a new study has found. Ribociclib (brand name Kisqali) is a CDK4/6 inhibitor, a type of drug that targets specific enzymes — including the protein CDK6 — to stop...
Father created a drug to save his son from a rare disease, now other families are desperate to get it
When his infant son was diagnosed with a rare disease, a Canadian father was dismayed to discover there was no treatment or cure. So he set out to make one himself. Terry Pirovolakis, an IT director in Toronto, Ontario, welcomed his third son in Dec. 2017. It was a “normal, healthy birth,” he told Fox...
New COVID vaccines get FDA approval for 2024-2025 season
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully approved for people 12 years and older, while the Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine were granted emergency authorization for children 6 months through 11...
Ozempic push for seniors? Some doctors say more people age 65 and over should be on it
Just 9% of older adults age 65 and up say they have taken GLP-1 drugs like Ozempic, Wegovy and Mounjaro, according to recent data from KFF Health — and only 1% said they take the medications just for weight-loss purposes. Some doctors are recommending that more adults in these older age groups incorporate the drugs...
Doctors can stop severe bleeding ‘in seconds’ with newly approved trauma product
The U.S. Food and Drug Administration (FDA) has approved a novel treatment that is designed to stop severe bleeding in a matter of seconds. TRAUMAGEL — made by Cresilon Inc., a Brooklyn-based biotechnology company — is a plant-based hydrogel that comes in a pre-filled syringe, according to a press release. First responders, paramedics and combat...
Arrests in Matthew Perry's death put spotlight on ketamine dangers
Recent arrests made in actor Matthew Perry’s death have cast new light on the dangers of ketamine abuse. Perry’s Oct. 28th death — which initially appeared to be a drowning in a hot tub at his California home — was later attributed to the “acute effects of ketamine,” as ruled by the Los Angeles County...
Cure for men's hair loss could be found in sugar stored in the body, study suggests
The cure for male pattern baldness could already be in the human body. The condition, which causes gradual hair loss, affects up to 50% of men worldwide. Researchers at the University of Sheffield in the U.K. claim the fix might be found in a sugar that’s naturally present in the human body. HAIR LOSS AND...
American Society of Plastic Surgeons breaks consensus of medical establishment on transgender care
The American Society of Plastic Surgeons (ASPS) is breaking with the consensus of the American medical establishment about best practices in so-called “gender-affirming care” for minors. The organization’s move, which represents 92% of all board-certified plastic surgeons in the U.S., comes amid shifting international sentiment that psychotherapy might be a better course of action in...









